Join
Live feed
·
INSIDERFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

President, CEO Khattar Jack A. acquired 12,500 shares, disposed of 12,500 shares and sold $1,763,124 worth of shares (35,000 units at $50.37), increasing direct ownership by 1% to 1,241,144 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.